Cel-Sci In Meltdown As Investors Unconvinced By CEO’s Spin On Drug Failure

Refutes Accusations Of Data Manipulation

 
• By Andrew McConaghie
  
Cel-Sci
Cel-Sci has been around for nearly 40 years without launching a product, but looks to be running out of options. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip